Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Determinants of airflow limitation in Danish adults - findings from the Health2006 cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A clinical prediction model for hospitalized COPD exacerbations based on "treatable traits"

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effects of community-based pulmonary rehabilitation in 33 municipalities in Denmark - results from the KOALA project

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Opportunistic screening for COPD in primary care: a pooled analysis of 6,710 symptomatic smokers and ex-smokers

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Automated oxygen control with O2matic® during admission with exacerbation of COPD

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Passiv rygning er en risikofaktor for udvikling af nedsat lungefunktion og KOL

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Predictors of COPD in symptomatic smokers and ex-smokers seen in primary care

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Behandlingsniveau og behandlingsstop ved benign lungesygdom

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Effect of tele-health care on quality of life in patients with severe COPD: a randomized clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Purpose: This study investigated the effect of dual bronchodilation with the long-acting β-receptor agonist/long-acting muscarinic antagonist combination, indacaterol/glycopyrronium (IND/GLY), on nighttime oxygenation, lung function, sleep quality, and symptoms in patients with moderate-to-severe COPD.

Patients and methods: This was a 4-week, double-blind, multicenter, placebo-controlled, two-period crossover study. Patients were randomized in a 1:1 ratio to receive IND/GLY 110/50 µg once daily or matching placebo. The primary objective was to evaluate the effect of treatment with IND/GLY on mean nighttime oxygenation, compared with placebo. The secondary objective was to determine the time spent <90% in blood oxygen saturation (SpO2) compared with placebo. Exploratory objectives were to assess the effect of IND/GLY, compared with placebo, on sleep quality measured by the Medical Outcomes Study (MOS) Sleep Scale and the COPD and Asthma Sleep Impact Scale (CASIS) questionnaires and on symptoms assessed by COPD Assessment Test (CAT) questionnaire.

Results: In total, 38 patients were randomized (n=22, IND/GLY; n=16, placebo). The change in nighttime oxygenation (SpO2) was similar, and there was a comparable difference in time spent <90% SpO2 between IND/GLY and placebo. Increases from baseline for the difference between IND/GLY and placebo for trough FEV1, FVC, and inspiratory capacity (P<0.05) were seen, with a corresponding reduction in residual volume and functional residual capacity (P<0.05). IND/GLY treatment showed an improvement in scores for CAT (P=0.0208), CASIS, and the MOS Sleep Scale measures, Sleep Problems Index I, Sleep Problems Index II (P=0.0315), Sleep Adequacy, Sleep Disturbance Scale, Somnolence Scale, and Short of Breath Scale (P=0.0031).

Conclusion: In this study, IND/GLY 110/50 µg once daily improved symptoms, sleep quality, and lung function, but showed no effect on nighttime oxygenation in patients with moderate-to-severe COPD.

Original languageEnglish
JournalInternational Journal of Chronic Obstructive Pulmonary Disease
Volume14
Pages (from-to)199-210
Number of pages12
ISSN1178-2005
DOIs
Publication statusPublished - 1 Jan 2019

    Research areas

  • Bronchodilator, Hypoxia, Lung function, Quality of life, Sleep

ID: 56376451